JAVIER DAVIS: Open Payments
NPI 1841907714 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 10 payments from 8 companies in 2025. Trend: 2023 $216 · 2024 $938 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $250 |
| Amgen Inc. | 1 | $148 |
| Braeburn Inc. | 2 | $141 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
Products named: FANAPT, BRIXADI, Auvelity, REXULTI, AUSTEDO XR, CAPLYTA.
Industry payments across AL — which companies pay providers there.
